Interaction between Alzheimer's Aβ(25-35) peptide and phospholipid bilayers: The role of cholesterol

Biochimica et Biophysica Acta - Biomembranes

Volumn 1778, Issue 12, 2008, Pages 2710-2716

  D'Errico, Gerardino ^a   Vitiello, Giuseppe ^a   Ortona, Ornella ^a   Tedeschi, Annamaria ^b   Ramunno, Anna ^b   D'Ursi, Anna Maria ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

Alzheimer disease; Amyloid peptides; Cholesterol; Electron paramagnetic resonance; Phospholipids

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; CHOLESTEROL; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL;

ALZHEIMER DISEASE; ARTICLE; BILAYER MEMBRANE; ELECTRON SPIN RESONANCE; HYDROPHOBICITY; MOLECULAR INTERACTION; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CHOLESTEROL; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; LIPID BILAYERS; PEPTIDE FRAGMENTS; PEPTIDES; PHOSPHOLIPIDS;

EID: 55749114033     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2008.07.014     Document Type: Article

References (47)

1. Alzheimer A. Ueber eigenartige erkrankung der hirnrinden. Allg. Ztschr. Für Psychiat. 64 (1907) 146-148
2. Herz J. Overview: the long and winding road to understanding Alzheimer's disease. Neuron 53 (2007) 477-479
3. Selkoe D.J. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol. 10 (1994) 373-403
4. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399 (1999) A23-A31
5. Mclean C.A., Cherny R.a., Fraser F.W., Fuller S.J., Smith M.J., Beyreuther K., Bush A.I., and Masters C.L. Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46 (1999) 860-866
6. Hsia A.Y., Masliah E., McConlogue L., Yu G.Q., Tatsuno G., Hu K., Kholodenko D., Malenka R.C., Nicoll R.A., and Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 3228-3233
7. Hartley D.M., Walsh D.M., Ye C.P., Diehl T., Vasquez S., Vassilev P.M., Teplow D.B., and Selkoe D.J. Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical meurons. J. Neurosci. 19 (1999) 8876-8884
8. Mattson M.P., Barger S.W., Cheng B., Lieberburg I., Smith-Swintosky V.L., and Rydel R.E. β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16 (1993) 409-414
9. Arispe N., Rojas E., and Pollard H.B. Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminium. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 567-571
10. Ambroggio E.E., Kim D.H., Separovic F., Barrow C.J., Barnham K.J., Bagatolli L.A., and Fidelio G.D. Surface behaviour and lipid interaction of Alzheimer β-amyloid peptide 1-42: a membrane-disrupting peptide. Biophys. J. 88 (2005) 2706-2713
11. Terzi E., Hölzemann G., and Seelig J. Alzheimer β-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes. Biochemistry 33 (1994) 7434-7441
12. del Mar Martínez-Senac M., Villalain J., and Gómez-Fernández J.C. Structure of the Alzheimer β-amyloid peptide (25-35) and its interaction with negatively charged phospholipids vesicles. Eur. J. Biochem. 265 (1999) 744-753
13. Mason R.P., Estermyer J.D., Kelly J.F., and Mason P.E. Alzheimer's disease amyloid 13 peptide 25-35 is localized in the membrane hydrocarbon core: X-ray diffraction analysis. Biochem. Biophys Res. Comm. 222 (1996) 78-82
14. Dante S., Hauss T., and Dencher N.A. β-Amyloid 25 to 35 is intercalated in anionic and zwitterionic lipid membranes to different extents. Biophys. J. 83 (2002) 2610-2616
15. Dante S., Hauss T., and Dencher N.A. Insertion of externally administered amyloid β peptide 25-35 and perturbation of lipid bilayers. Biochemistry 42 (2003) 13667-13672
16. Lau T.L., Gehman J.D., Wade J.D., Perez K., Masters C.L., Barnham K.J., and Separovic F. Membrane interactions and the effect of metal ions of the amyloidogenic fragment Aβ(25-35) in comparison to Aβ(1-42). Biochim. Biophys. Acta. 1768 (2007) 2400-2408
17. Puglielli L., Tanzi R.E., and Kovacs D.M. Alzheimer's disease: the cholesterol connection. Nat. Neurosci. 6 (2003) 345-351
18. Wolozin B. Cholesterol and the biology of Alzheimer's disease. Neuron 41 (2004) 7-10
19. Ledesma M.D., and Dotti C.G. Amyloid excess in Alzheimer's disease: what is cholesterol to be blamed for?. FEBS Lett. 580 (2006) 5525-5532
20. Mason R.P., Shoemacker W.J., Shajenko L., Chambers T.E., and Herbette L.G. Evidence for changes in the Alzheimer desease brain cortical membrane structure mediated by cholesterol. Neurobiol. Aging 13 (1992) 413-419
21. Lin M.C., and Kagan B.L. Electrophysiologic properties of channel induced by Aβ(25-35) in planar lipid bilayers. Peptides 23 (2002) 1215-1228
22. Dante S., Hauss T., and Dencher N.A. Cholestrol inhibits the insertion of the Alzheimer's peptide Aβ(25 to 35) in lipid bilayers. Eur. Biophys. J. 35 (2006) 523-531
23. Esposito C., Tedeschi A.M., Scrima M., D'Errico G., Ottaviani M.F., Rovero P., and D'Ursi A.M. Exploring interaction of β-amyloid segment (25-35) with membrane models through paramagnetic probes. J. Pept. Sci. 12 (2006) 766-774
24. Marsh D., and Horvath L.I. Structure, dynamics and composition of the lipid-protein interface. Perspectives from spin-labelling. Biochim. Biophys. Acta. 1376 (1998) 267-296
25. Marsh D. Application of electron spin resonance for investigating peptide-lipid interactions, and correlation with thermodynamics. Biochem. Soc. Trans. 29 (2001) 582-589
26. Jao S.C., Ma K., Talafous J., Orleo R., and Zagorski M.G. Trifluoroacetic acid pretreatment reproducibly disaggregates the amyloid β-peptide. Amyloid 4 (1997) 240-252
27. Moser M., Marsh D., Meier P., Wassmer K.-H., and Kothe G. Chain configuration and flexibility gradient in phospholipid membranes. Comparison between spin-label electron spin resonance and deuteron nuclear magnetic resonance, and identification of new conformations. Biophys. J. 55 (1989) 111-123
28. Swamy M.J., and Marsh D. Spin-label electron spin resonance studies on the dynamics of the different phases of N-biotinylphosphatidylethanolamines. Biochemistry 33 (1994) 11656-11663
29. Feigenson G.W., and Buboltz J.T. Ternary phase diagram of dipalmitoyl-PC/dilauroyl-PC/cholesterol: nanoscopic domain formation driven by cholesterol. Biophys. J. 80 (2001) 2775-2788
30. Chiang Y.W., Shimoyama Y., Feigenson G.W., and Freed J.H. Dynamic molecular structure of DPPC-DLPC-Cholesterol ternary lipid system by spin-label electron spin resonance. Biophys. J. 87 (2004) 2483-2496
31. Ramakrishnan M., Jensen P.H., and Marsh D. α -synuclein association with phosphatidylglycerol probed by lipid spin labels. Biochemistry 42 (2003) 12919-12926
32. D'Errico G., D'Ursi A.M., and Marsh D. Interaction of a peptide derived from glycoprotein gp36 of Feline Immunodeficiency Virus and its lipoylated analogue with phospholipid membranes. Biochemistry 47 (2008) 5317-5327
33. Rochet J.C., and Lansbury P.T. Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol. 10 (2000) 60-68
34. Brender J.R., Lee E.L., Cavitt M.A., Gafni A., Steel D.G., and Ramamoorthy A. Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide. J. Am. Chem. Soc. 130 (2008) 6424-6429
35. Brender J.R., Dürr U.H.N., Heyl D., Badarapu M.B., and Ramamoorthy A. Membrane fragmentation by an amyloidogenic fragment of human islet amyloid polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes. Biochim. Biophys. Acta. 1768 (2007) 2026-2029
36. Engel M.F.M., Yigittop H., Elgersma R.C., Rijkers D.T.S., Liskamp R.M.J., de Kruijff B., Höppener J.W.M., and Killian J.A. Islet amyloid polypeptide inserts into phospholipids monolayers as monomers. J. Mol. Biol. 356 (2006) 783-789
37. Pike C.J., Walencewicz-Wasserman A.J., Kosmoski J., Cribbs D.H., Glabe C.G., and Cotman C.W. Structure-activity analyses of β-amyloid peptides: contributions of the β 25-35 region to aggregation and neuro toxicity. J. Neurochem. 64 (1995) 253-265
38. Lin M.C., and Kagan B.L. Electrophysiologic properties of channels induced by Aβ(25-35) in planar lipid bilayers. Peptides 23 (2002) 1215-1228
39. Kohno T., Kobayashi K., Maeda T., Sata K., and Takashima A. Three-dimensional structures of the amyloid b peptide (25-35) in membrane-mimicking environment. Biochemistry 35 (1996) 16094-16104
40. D'Ursi A.M., Armenante M.R., Guerrini R., Salvatori S., Sorrentino G., and Picone D. J. Med. Chem. 47 (2004) 4231-4238
41. R.H. Ashley, T.A. Harroun, T. Hauss, K.C. Breen, J.P. Bradshaw, Autoinsertion of soluble oligomers of Alzheimer's Ab (1-42) peptide into cholesterol-containing membranes is accompanied by relocation of the sterol towards the bilayer surface, BMC Structural Biology 6 (2006) 21 doi:10.1186/1472-6807-6-21.
42. Lau T.L., Gehman J.D., Wade J.D., Masters C.L., Barnham K.J., and Separovic F. Cholesterol and Clioquinol modulation of Aβ(1-42) interaction with phospholipid bilayers and metals. Biochim. Biophys. Acta. 1768 (2007) 3135-3144
43. Toselli M., Biella G., Taglietti V., Cazzaniga E., and Parenti M. Caveolin-1 expression and membrane cholesterol content modulate N.type Calcium channel activity in NG108-15 cells. Biophys. J. 89 (2005) 2443-2457
44. Matsuzaki K. Physicochemical interactions of amyloid b-peptide with lipid bilayers. Biochim. Biophys. Acta. 1768 (2007) 1935-1942
45. Bokvist M., Lindström F., Watts A., and Gröbner G. Two types of Alzheimer's b-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. J. Mol. Biol 335 (2004) 1039-1049
46. Hallock K.J., Lee D.K., Omnaas J., Mosberg H.I., and Ramamoorthy A. Membrane composition determines pardaxin's mechanism of lipid bilayer disruption. Biophys. J. 83 (2002) 1004-1013
47. Ramamoorthy A., Thennarasu S., Tan A., Lee D.K., Clayberger JC., and Krensky A.M. Cell selectivity correlates with membrane-specific interactions: a case study on the antimicrobial peptide G15 derived from granulysin. Biochim. Biophys. Acta. 1758 (2006) 154-163